{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T22:10:06Z","timestamp":1773007806672,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.leukres.2011.06.030","type":"journal-article","created":{"date-parts":[[2011,7,23]],"date-time":"2011-07-23T23:47:39Z","timestamp":1311464859000},"page":"1557-1563","source":"Crossref","is-referenced-by-count":31,"title":["Low impact of cardiovascular adverse events on anagrelide treatment discontinuation in a cohort of 232 patients with essential thrombocythemia"],"prefix":"10.1016","volume":"35","author":[{"given":"Luigi","family":"Gugliotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Tieghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Tortorella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Potito Rosario","family":"Scalzulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Ciancia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monia","family":"Lunghi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Cacciola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Cacciola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Candoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Crugnola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Codeluppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Usala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgina","family":"Specchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Pierri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Marina","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Iurlo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Grossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro M.","family":"Vannucchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Vianelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Gabriella","family":"Mazzucconi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2011.06.030_bib0005","first-page":"51","article-title":"Anagrelide for control of thrombocythemia in polycythemia vera and other myeloproliferative disorders","volume":"34","author":"Petitt","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0010","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.leukres.2004.10.002","article-title":"Anagrelide: analysis of long-term efficacy, safety and leukemogenic potential in myeloproliferative disorders","volume":"29","author":"Fruchtman","year":"2005","journal-title":"Leuk Res"},{"key":"10.1016\/j.leukres.2011.06.030_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa043800","article-title":"Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia","volume":"353","author":"Harrison","year":"2005","journal-title":"NEJM"},{"key":"10.1016\/j.leukres.2011.06.030_bib0020","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood.V112.11.661.661","article-title":"Final results of the ANAHYDRET-study: non-inferiority of anagrelide compared to hydroxyurea in newly diagnosed WHO-essential thrombocythemia patients","volume":"112","author":"Gisslinger","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.030_bib0025","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1182\/blood.V97.4.863","article-title":"Long-term use of anagrelide in young patients with essential thrombocythemia","volume":"97","author":"Storen","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.030_bib0030","first-page":"921a","article-title":"Anagrelide in essential thrombocythemia: a retrospective analysis of 220","volume":"102","author":"Gugliotta","year":"2003","journal-title":"Patients Blood"},{"key":"10.1016\/j.leukres.2011.06.030_bib0035","first-page":"1306","article-title":"A long-term study of young patients with essential thrombocythemia treated with anagrelide","volume":"89","author":"Mazzucconi","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.06.030_bib0040","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1600-0609.2006.00719.x","article-title":"Long-term use of anagrelide in the treatment of children with essential thrombocythemia","volume":"77","author":"Lackner","year":"2006","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0045","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V112.11.664.664","article-title":"Retrospective evaluation of 90 children with essential thrombocytemia: The AIEOP experience","volume":"112","author":"Putti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2011.06.030_bib0050","first-page":"215","article-title":"Practice guideline for the therapy of essential thrombocythemia. A statement from the Italian Society of Experimental Haematology and the Italian Group for Bone Marrow Transplantation","volume":"89","author":"Barbui","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.06.030_bib0055","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1517\/14656566.1.3.537","article-title":"Anagrelide: a novel agent for the treatment of myeloproliferative disorders","volume":"1","author":"Pescatore","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.leukres.2011.06.030_bib0060","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1055\/s-2006-939437","article-title":"Anagrelide treatment in myeloproliferative disorders","volume":"32","author":"Birgegard","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.leukres.2011.06.030_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14737140.9.1.37","article-title":"Anagrelide: 20 years later","volume":"9","author":"Emadi","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.leukres.2011.06.030_bib0070","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1200\/JCO.1990.8.3.556","article-title":"Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia","volume":"8","author":"Cortelazzo","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/sj.leu.2401270","article-title":"Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients","volume":"13","author":"Besses","year":"1999","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2011.06.030_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1365-2796.1998.00314.x","article-title":"Acute coronary disease in essential thrombocythemia and polycythemia vera","volume":"244","author":"Rossi","year":"1998","journal-title":"J Intern Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0085","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1592\/phco.20.15.1224.34591","article-title":"Anagrelide-induced cardiomyopathy","volume":"20","author":"James","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.leukres.2011.06.030_bib0090","first-page":"520","article-title":"Adverse effects and benefits of two years of anagrelide treatment for thrombocythemia in chronic myeloproliferative disorders","volume":"89","author":"Birgeg\u00e5rd","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.06.030_bib0095","doi-asserted-by":"crossref","first-page":"311","DOI":"10.7326\/0003-4819-143-4-200508160-00020","article-title":"High-output heart failure associated with anagrelide therapy for essential thrombocytosis","volume":"143","author":"Engel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0100","first-page":"1394","article-title":"Anagrelide-associated cardiomyopathy in policitemia vera and essential thrombocythemia","volume":"89","author":"Jurgens","year":"2004","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.06.030_bib0105","series-title":"EXELS study: evaluation of Xagrid efficacy and long-term safety","author":"Birgegard","year":"2009"},{"key":"10.1016\/j.leukres.2011.06.030_bib0110","first-page":"29","article-title":"Experience of the Polycythemia Vera Study Group with essential thrombocythemia: a final report on diagnostic criteria, survival, and leukemic transition by treatment [review] [35 refs]","volume":"34","author":"Murphy","year":"1997","journal-title":"Semin Hematol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0115","series-title":"WHO Classification of Tumors: Tumors of Haematopoietic and Lymphoid Tissues","first-page":"39","article-title":"Essential thrombocythemia","author":"Imbert","year":"2001"},{"key":"10.1016\/j.leukres.2011.06.030_bib0120","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0002-9343(92)90017-6","volume":"92","year":"1992","journal-title":"Am J Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0609.1998.tb01064.x","article-title":"Anagrelide, a novel platelet lowering option in essential thrombocythaemia: treatment experience in 48 patients in Germany","volume":"61","author":"Petrides","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00277-008-0531-7","article-title":"Long-term management of thrombocytosis in essential thrombocythaemia","volume":"88","author":"Birgeg\u00e5rd","year":"2009","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0002-9343(97)89451-X","article-title":"Evaluation and outcomes of patients with palpitations","volume":"100","author":"Weber","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0140","doi-asserted-by":"crossref","first-page":"832","DOI":"10.7326\/0003-4819-134-9_Part_2-200105011-00006","article-title":"Palpitations, arrhythmias, and awareness of cardiac activity","volume":"134","author":"Barsky","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0145","first-page":"6","article-title":"How to manage palpitations when treating ET","volume":"3","author":"Martinez-Selles","year":"2009","journal-title":"Myloproliferative Disord Pract"},{"key":"10.1016\/j.leukres.2011.06.030_bib0150","first-page":"409","article-title":"Anagrelide treatment and prospective cardiovascular evaluation in essential thrombocythaemia patients: a pilot study of the Registro Italiano Trombocitemia (RIT)","volume":"95","author":"Gugliotta","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.leukres.2011.06.030_bib0155","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/qjmed\/hcg017","article-title":"Characteristics of patients presenting to a cardiac clinic with palpitation","volume":"96","author":"Mayou","year":"2003","journal-title":"QJM Oxford J Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0160","first-page":"743","article-title":"Diagnostic approach to palpitations","volume":"71","author":"Abbott","year":"2005","journal-title":"Am Fam Physician J"},{"key":"10.1016\/j.leukres.2011.06.030_bib0165","unstructured":"Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Reimer WS, Weissberg P, Wood D, Yarnell J, Zamorano JL. Quarta Task Force Congiunta della Societ\u00e0 Europea di Cardiologia e Societ\u00e0 sulla Prevenzione delle Malattie Cardiovascolari nella Pratica Clinica (costituita da altre nove societ\u00e0 ed esperti invitati) Collaborators: Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Hellemans I, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A. European practice guidelines on prevention of cardiovascular diseases: executive summary [Article in Italian]. G Ital Cardiol 2008; 9: 11\u201359."},{"key":"10.1016\/j.leukres.2011.06.030_bib0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00277-008-0451-6","article-title":"Successful rechallenge with anagrelide in a patient with anagrelide-associated cardiomyopathy","volume":"87","author":"Wong","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.leukres.2011.06.030_bib0175","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1515\/CCLM.2009.038","article-title":"New European guidelines for cardiovascular disease prevention in clinical practice","volume":"47","author":"De Backer","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.leukres.2011.06.030_bib0180","first-page":"94","article-title":"Anagrelide e inibitori delle fosfodiesterasi","volume":"2","author":"Tortorella","year":"2009","journal-title":"Cardiol Ambul"},{"key":"10.1016\/j.leukres.2011.06.030_bib0185","unstructured":"Shire, Xagrid Summary of Product Characteristics; May 2011."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003201?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212611003201?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,21]],"date-time":"2020-06-21T15:19:33Z","timestamp":1592752773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212611003201"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0145212611003201"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2011.06.030","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}